Strategies to reduce renal risks associated with the use of contrast
DOI:
https://doi.org/10.56294/shp2024131Keywords:
CI-AKI, nephrotoxicity, prevention, Contrast Media, ArgentinaAbstract
The use of contrast agents transformed diagnostic and therapeutic procedures, allowing for better internal visualisation. However, it also generated complications such as contrast-induced acute kidney injury (CI-AKI), especially in patients with risk factors such as chronic kidney disease, diabetes or heart failure. In Argentina, during 2024, the importance of evaluating patients before the use of contrast, adequate hydration and the use of low-osmolality agents was recognised. Strategies such as standardised protocols, medical training and monitoring were established to reduce the incidence of this complication. Prevention and equitable access to resources were key to improving renal health outcomes.
References
1. Shams E, Mayrovitz HN. Contrast-Induced Nephropathy: A Review of Mechanisms
and Risks [Internet]. Cureus; 2021 May 4 [cited 2024 Oct 4]. Available from:
https://www.cureus.com/articles/58401-contrast-induced-nephropathy-a-review-
of-mechanisms-and-risks
2. Mamoulakis C, Tsarouhas K, Fragkiadoulaki I, Heretis I, Wilks MF, Spandidos DA, et
al. Contrast-induced nephropathy: Basic concepts, pathophysiological implications
and prevention strategies. Pharmacol Ther. 2017 Dec;180:99–112.
3. Contrast Media Safety Committee. ESUR Guidelines on Contrast Agents, version
10.0. European Society of Urogenital Radiology; 2018.
4. Gorelik Y, Yaseen H, Heyman SN, Khamaisi M. Negligible risk of acute renal failure
among hospitalized patients after contrast-enhanced imaging with iodinated
versus gadolinium-based agents. Invest Radiol. 2019 May;54(5):312–8.
5. McDonald RJ, McDonald JS, Bida JP, Carter RE, Fleming CJ, Misra S, et al.
Intravenous contrast material–induced nephropathy. Contrast Media. 2013;267(1).
6. Qian G, Liu C, Guo J, Dong W, Wang J, Chen Y. Prevention of contrast-induced
nephropathy by adequate hydration combined with isosorbide dinitrate for
patients with renal insufficiency and congestive heart failure. Clin Cardiol. 2019
Jan;42(1):21–5.
7. Sun Z, Fu Q, Cao L, Jin W, Cheng L, Li Z. Intravenous N-acetylcysteine for
prevention of contrast-induced nephropathy: A meta-analysis of randomized,
controlled trials. PLoS One. 2013 Jan 30;8(1):e55124.
8. Weisbord SD, Palevsky PM, Kaufman JS, Wu H, Androsenko M, Ferguson RE, et al.
Contrast-associated acute kidney injury and serious adverse outcomes following
angiography. J Am Coll Cardiol. 2020 Mar;75(11):1311–20.
9. Cheungpasitporn W, Thongprayoon C, Brabec B, Edmonds P, O′Corragain O,
Erickson S. Oral hydration for prevention of contrast-induced acute kidney injury
in elective radiological procedures: A systematic review and meta-analysis of
randomized controlled trials. N Am J Med Sci. 2014;6(12):618.
10. Lee T, Kim WK, Kim AJ, Ro H, Chang JH, Lee HH, et al. Low-osmolar vs. iso-
osmolar contrast media on the risk of contrast-induced acute kidney injury: A
propensity score matched study. Front Med. 2022 Apr 29;9:862023.
11. Everson M, Sukcharoen K, Milner Q. Contrast-associated acute kidney injury. BJA
Educ. 2020 Dec;20(12):417–23.
12. Van Der Molen AJ, Dekkers IA, Bedioune I, Darmon-Kern E. A systematic review of
the incidence of hypersensitivity reactions and post-contrast acute kidney injury
after ioversol in more than 57,000 patients: part 1—intravenous administration.
Eur Radiol. 2022 Mar 21;32(8):5532–45.
13. Ehrmann S, Quartin A, Hobbs BP, Robert-Edan V, Cely C, Bell C, et al. Contrast-
associated acute kidney injury in the critically ill: systematic review and Bayesian
meta-analysis. Intensive Care Med. 2017 Jun;43(6):785–94.
14. Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, et al. Use of
intravenous gadolinium-based contrast media in patients with kidney disease:
Consensus statements from the American College of Radiology and the National
Kidney Foundation. Radiology. 2021 Jan;298(1):28–35.
15. Honda T, Kuriyama K, Kiso K, Kishimoto K, Tsuboyama T, Inoue A, et al. Incidence
rate of severe adverse drug reactions to nonionic contrast media at the National
Hospital Organization Osaka National Hospital. Allergo J Int. 2020
Nov;29(7):240–4.
16. Cha MJ, Kang DY, Lee W, Yoon SH, Choi YH, Byun JS, et al. Hypersensitivity
reactions to iodinated contrast media: A multicenter study of 196,081 patients.
Radiology. 2019 Oct;293(1):117–24.
17. Gomi T, Nagamoto M, Hasegawa M, Katoh A, Sugiyama M, Murata N, et al. Are
there any differences in acute adverse reactions among five low-osmolar non-
ionic iodinated contrast media? Eur Radiol. 2010 Jul;20(7):1631–5.
Published
Issue
Section
License
Copyright (c) 2024 Aline Aparecida Pacheco , Analía Claudia Sabattini (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
